98O: Characterization of Tumor Infiltrating Lymphocytes in Resectable Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/s1556-0864(16)30211-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

MA11.03 Interaction of Tumor Infiltrating Lymphocytes and Cancer Nuclei Predicts Response to Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Cysts Mark the Early Stage of Metastatic Tumor Development in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Durvalumab for Non-Resectable Stage IIIB Non-Small Cell Lung Cancer—a Small Step or a Big Leap?

Translational Lung Cancer Research
Oncology
2018English

Relationship Between Tumor Size and Disease Stage in Non-Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Chemotherapy Uptake and Wait Times in Early-Stage Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2012English

Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy